Nicolas Epaillard
Impact in
-
- Renal cell carcinoma treatment
- Ferroptosis and cancer prognosis
- Brain Metastases and Treatment
-
- Cancer Genomics and Diagnostics
Papers in
-
- Renal cell carcinoma treatment 6
- Sarcoma Diagnosis and Treatment 2
- Oncology 12
- Cancer Immunotherapy and Biomarkers 7
- COVID-19 and healthcare impacts 3
- Inflammatory Biomarkers in Disease Prognosis 2
- Co-authors
- Stéphane Oudard (8 shared papers)Marco Moreira (4 shared papers)Yann Vano (6 shared papers)Audrey Simonaggio (4 shared papers)Barbara Pistilli (3 shared papers)Réza Elaidi (2 shared papers)Constance Thibault (2 shared papers)Cheng‐Ming Sun (2 shared papers)
In The Last Decade
Nicolas Epaillard
17 papers receiving 226 citations
Peers
Comparison fields: 5 of 37
- Pulmonary and Respiratory Medicine 149
- Cancer Research 59
- Oncology 106
- Molecular Biology 64
- Epidemiology 28
Countries citing papers authored by Nicolas Epaillard
This map shows the geographic impact of Nicolas Epaillard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Epaillard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Epaillard more than expected).
Fields of papers citing papers by Nicolas Epaillard
This network shows the impact of papers produced by Nicolas Epaillard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Epaillard. The network helps show where Nicolas Epaillard may publish in the future.
Co-authors
The 25 scholars most cited alongside Nicolas Epaillard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 45 | |
| 2 | 2020 | 42 | |
| 3 | 2020 | 35 | |
| 4 | 2023 | 24 | |
| 5 | 2023 | 17 | |
| 6 | 2020 | 14 | |
| 7 | 2021 | 12 | |
| 8 | 2019 | 11 | |
| 9 | 2021 | 9 | |
| 10 | 2020 | 4 | |
| 11 | 2024 | 3 | |
| 12 | 2020 | 2 | |
| 13 | 2025 | 2 | |
| 14 | 2020 | 2 | |
| 15 | 2021 | 2 | |
| 16 | 2020 | 1 | |
| 17 | 2020 | 1 | |
| 18 | 2021 | 0 | |
| 19 | 2023 | 0 | |
| 20 | 2020 | 0 |
About Nicolas Epaillard
Nicolas Epaillard is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Cancer Research and Surgery, having authored 22 papers that have together received 226 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (7 papers), Renal cell carcinoma treatment (6 papers), Cancer Genomics and Diagnostics (4 papers), Renal and related cancers (3 papers), COVID-19 and healthcare impacts (3 papers), Inflammatory Biomarkers in Disease Prognosis (2 papers), COVID-19 Clinical Research Studies (2 papers) and Sarcoma Diagnosis and Treatment (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (149 citations), Cancer Research (59 citations), Oncology (106 citations), Molecular Biology (64 citations) and Epidemiology (28 citations). Nicolas Epaillard has collaborated with scholars based in France, Spain and Italy. Frequent co-authors include Stéphane Oudard, Marco Moreira, Yann Vano, Audrey Simonaggio, Barbara Pistilli, Réza Elaidi, Constance Thibault, Cheng‐Ming Sun, Luc Cabel and Anne Vincent‐Salomon. Their work appears in journals such as Annals of Oncology, Clinical Microbiology and Infection, Oral Oncology, ESMO Open and Cancer Treatment Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.